News

Columbus CyberKnife Celebrates Five-Year Anniversary

This month, Columbus CyberKnife honors five years of cancer care since opening on the campus of hospital partner Mount Carmel St. Ann’s Hospital.

Research Shows Stereotactic Radiosurgery for Metastatic Brain Tumors Improves Survival Rates for Patients Under 50

In a recent study, researchers demonstrated the efficacy of stereotactic radiosurgery (SRS) in the treatment of brain metastases, or tumors that have spread from a primary tumor in another area of the body to the brain.

Men’s Health Week: Prostate Cancer and Second Opinions

June 15 - 21 is honored as Men’s Health Week, dedicated to raising awareness for all aspects of men’s health.

Metastatic Lung Cancer: CyberKnife Treatment Effective According to Recent Study

In a recent study examining the efficacy of CyberKnife for the treatment of lung cancer metastases, researchers determined that patients may experience better local control and low toxicity.

New Study Shows CyberKnife Effective for Localized Prostate Cancer

A recent prostate cancer study examined the outcomes of CyberKnife treatment for low and immediate risk patients with early stage prostate cancer.

Patient Perspectives: ‘How Will the Treatment Affect my Daily Routine?’

For some patients, maintaining a daily routine is important, particularly for those who work or travel. Fortunately, as cancer technology and approaches to treatment have advanced, there are options and methods available that can help to reduce the impact of cancer treatment on a patient’s daily routine.

Words From Our Patients: Prostate Cancer Treatment at Columbus CyberKnife

CyberKnife offers an effective and convenient cancer treatment option. Watch the video in this post to hear about the experience of Ward, a former CyberKnife prostate cancer patient.

Acoustic Neuroma Awareness Week: How CyberKnife Can Help

Acoustic Neuroma Awareness Week 2015 is celebrated nationwide May 10 – 16.

Recent Studies Support CyberKnife Treatment for Neurological Diseases

Two studies presented at the 2014 annual meeting of the European Association of Neurosurgical Societies (EANS) reinforce the benefits of stereotactic radiosurgery for neurological diseases using the CyberKnife® system.

Brain Tumor Awareness Month: Treatment Options for Recurrent Tumors

Each May, communities come together to honor Brain Tumor Awareness Month by spotlighting those impacted by a brain tumor diagnosis and the need for greater understanding of the disease and its treatment options.